Skip to main content
. 2018 Jan 10;13(1):e0189247. doi: 10.1371/journal.pone.0189247

Table 4. Main pharmacological activities identified in compound 4.

Activity Inhibition of indicated activity (IC50, μM) a
TSLP production (NHBE) 0.075 b
PI3K (p110δ/p85α) 0.233
DNA-PK 0.348
MT3 (QR2) 0.4
PDE6 0.58
PDE5 0.92
mTOR 0.964
Yes 2.386
Ftl4 3.132
TrkA 3.232
Hck 3.581
Lck 3.330
PI3K (p120γ) 4.782

a Except for TSLP, all IC50 activities are based on biochemical assays dose response curves with duplicate determinations for each concentration.

b Activity as indicated in Fig 5.